Paul Tulcinsky

Commercial Services

Miscellaneous

Profile

Paul Tulcinsky is the founder of Convert Pharmaceuticals SA, founded in 2017, and OncoRadiomics SA, founded in 2016.
He also worked at Linklaters & Alliance in 2004.

Former positions of Paul Tulcinsky

Companies	Position	End
OncoRadiomics SA OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous OncoRadiomics SA functions as a foundation or endowment. Its products include radiomix, distrim and virtual patient auatar. The company was founded by Ralph Leijenaar, Sean Walsh and Tulcinsky Paul on September 19, 2016 and is headquartered in Liège, Belgium.	Founder	-
Convert Pharmaceuticals SA Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium.	Founder	-

See the detail of Paul Tulcinsky's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies